Our study suggests that NSCLC patients who are preoperatively negative for all serum TMs, such as CEA, CYFRA21‐1, CA19‐9, and SCC Ag, represent a subgroup with a particularly good prognosis. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.